VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ADPT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ADPTAdaptive Biotechnologies Corporation
$29.04$4.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksADPTPrice Target
ADPT logo

Adaptive Biotechnologies Corporation (ADPT) Price Target Analysis

Updated Nov 6, 2026
Analyst Rating: Buy
Based on 17 analysts

13.3% Below Target

ADPT trades 13.3% below Wall Street's consensus target of $31.58.

Current Price$27.87
Average Target$31.58
Target
Current
Low$27.00
Median$33.00
High$35.00

Analyst Target Range

Forward P/E—
PEG Ratio—
Implied Growth-43.0%
(Declining)
Analyst Spread25.3%
(High Agreement)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$27.87
Consensus$31.58
High$35.00
Low$27.00

Consensus Scenario Assumptions

The base valuation assumes ADPT achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 17 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 17 published analyst recommendations for ADPT

24% hold / mixed conviction
+26
BearishBullish
Weighted analyst sentiment score based on 17 ratings
ConsensusBuy
Coverage17 Analysts
Net Score+26
Bull / Bear65% / 12%
Strong Buy00%
Buy1165%
Hold424%
Sell212%
Strong Sell00%
Strong Buy
00%
Buy
1165%
Hold
424%
Sell
212%
Strong Sell
00%
Recommendation Mix65% Buy · 24% Hold · 12% Sell
Buy (11)Hold (4)Sell (2)

ADPT Price Target Analysis

Updated November 16, 2026

As of November 16, 2026, Adaptive Biotechnologies Corporation (ADPT) has a Wall Street consensus price target of $31.58, based on estimates from 17 covering analysts. With the stock currently trading at $27.87, this represents a potential upside of +13.3%. The company has a market capitalization of $4.46B.

Analyst price targets range from a low of $27.00 to a high of $35.00, representing a 25% spread in expectations. The median target of $33.00 aligns closely with the consensus average.

The current analyst consensus rating is Buy, with 11 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 2 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.

From a valuation perspective, ADPT trades at a trailing P/E of -73.8x. Analysts expect EPS to grow -43.0% over the next year.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+24.7%
Industry Consensus
Avg Forward P/E
37.2x
(Growth Premium)
Peers with Coverage
10 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
NTRA logo
NTRANatera, Inc.
$41.3B$288.48$393.16
+36.3%
Buy—28
PACB logo
PACBPacific Biosciences of California, Inc.
$572M$1.84$1.93
+4.9%
Buy—18
TWST logo
TWSTTwist Bioscience Corporation
$6.5B$105.04$153.70
+46.3%
Buy—15
ILMN logo
ILMNIllumina, Inc.
$30.0B$198.00$252.73
+27.6%
Buy36.6x50
FLGT logo
FLGTFulgent Genetics, Inc.
$684M$24.07$19.00
-21.1%
Buy—9
CDNA logo
CDNACareDx, Inc
$3.8B$73.72$75.25
+2.1%
Buy41.4x14
VCYT logo
VCYTVeracyte, Inc.
$1.9B$24.01$54.14
+125.5%
Buy12.6x22
TMO logo
TMOThermo Fisher Scientific Inc.
$256.9B$691.33$694.27
+0.4%
Buy27.3x43
DHR logo
DHRDanaher Corporation
$161.8B$230.15$238.77
+3.7%
Buy26.8x43
RGEN logo
RGENRepligen Corporation
$9.2B$162.78$198.00
+21.6%
Buy78.5x24

ADPT — Frequently Asked Questions

Quick answers to the most common questions about buying ADPT stock.

What is the ADPT stock price target for 2026?

Adaptive Biotechnologies Corporation (ADPT) has a consensus 12-month price target of $31.58, implying 13.3% upside from $27.87. The 17 analysts covering ADPT see moderate appreciation potential.

Is ADPT a buy, sell, or hold?

ADPT has a consensus rating of "Buy" based on 17 Wall Street analysts. The rating breakdown is predominantly bullish, with 11 Buy/Strong Buy ratings. The consensus 12-month price target of $31.58 implies 13.3% upside from current levels.

Is ADPT stock overvalued or undervalued?

ADPT's current price is $27.87 with a consensus target of $31.58 (13.3% implied move). Analyst estimates suggest the stock is undervalued at current levels.

How high can ADPT stock go?

The most bullish Wall Street analyst has a price target of $35 for ADPT, while the most conservative target is $27. The consensus of $31.58 represents the median expectation. These targets typically reflect 12-month expectations.

How many analysts cover ADPT stock?

ADPT is well covered by analysts, with 17 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 11 have Buy ratings, 4 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the ADPT stock forecast?

The 12-month ADPT stock forecast based on 17 Wall Street analysts shows a consensus price target of $31.58, with estimates ranging from $27 (bear case) to $35 (bull case). The median consensus rating is "Buy".

Should I buy ADPT stock?

Wall Street analysts are optimistic on ADPT, with a "Buy" consensus rating and $31.58 price target (13.3% upside). 11 of 17 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do ADPT price targets vary so much?

ADPT analyst price targets range from $27 to $35, a 25% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $31.58 consensus represents the middle ground.

Consensus & Technical Research Suite
Open ADPT Terminal

ADPT Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare